A solution to one of Knuth's permutation problemsYOUNG, Benjamin.Comptes rendus. Mathématique. 2010, Vol 348, Num 13-14, pp 713-716, issn 1631-073X, 4 p.Article

The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapyYOUNG, Benjamin.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, pp S13-S20, issn 1525-4135, SUP1Conference Paper

Do new protease inhibitors offer improved clinical effectiveness? Issues of PI potency and efficacyYOUNG, Benjamin; MARKOWITZ, Martin.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, pp 3-12, issn 1525-4135, 10 p., SUP1Conference Paper

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trialVAN LUNZEN, Jan; MAGGIOLO, Franco; MIN, Sherene et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 2, pp 111-118, issn 1473-3099, 8 p.Article

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks : a randomised non-inferiority trialERONJR, Joseph; YENI, Patrick; SUTHERLAND-PHILLIPS, Denise et al.Lancet (British edition). 2006, Vol 368, Num 9534, pp 476-482, issn 0140-6736, 7 p.Article

Changes in the Use of HIVAntiretroviral Resistance Testing in a Large Cohort of U.S. Patients, 1999 to 2006BUCHACZ, Kate; BAKER, Rose K; YOUNG, Benjamin et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 5, pp 625-632, issn 1525-4135, 8 p.Article

An automated mobile phase preparation workstationSWINNEY, Kelly; YOUNG, Benjamin; JAKUBIK, Matthew E et al.Journal of chromatography. 2007, Vol 1141, Num 2, pp 182-190, issn 0021-9673, 9 p.Article

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsERON, Joseph J; YOUNG, Benjamin; KUMAR, Princy N et al.Lancet (British edition). 2010, Vol 375, Num 9712, pp 396-407, issn 0140-6736, 12 p.Article

First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North AmericaYOUNG, Benjamin; SQUIRES, Kathleen; PATEL, Parul et al.AIDS (London). 2008, Vol 22, Num 13, pp 1673-1675, issn 0269-9370, 3 p.Article

Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapyYOUNG, Benjamin; FRANSEN, Signe; GREENBERG, Kenneth S et al.Antiviral therapy (London). 2011, Vol 16, Num 2, pp 253-256, issn 1359-6535, 4 p.Article

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialERON, Joseph; ROCKSTROH, Jürgen K; NELSON, Mark et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 12, pp 907-915, issn 1473-3099, 9 p.Article

Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaELLIS, Rodney J; VERTOCNIK, Amy; DINCHMAN, Kurt H et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 362-370, issn 0360-3016, 9 p.Article

Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patientsSQUIRES, Kathleen E; YOUNG, Benjamin; DEJESUS, Edwin et al.AIDS (London). 2010, Vol 24, Num 13, pp 2019-2027, issn 0269-9370, 9 p.Article

Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects. CommentaryKURITZKES, Daniel R; GALLANT, Joel E; SHAEFER, Mark S et al.The Journal of infectious diseases. 2005, Vol 192, Num 11, pp 1867-1868, issn 0022-1899, 12 p.Article

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adultsYOUNG, Benjamin; FISCHL, Margaret A; WILSON, Helene M et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 5, pp 478-482, issn 1525-4135, 5 p.Article

Improving the fit of bivariate smoothing splines when estimating longitudinal immunological and virological markers in HIV patients with individual antiretroviral treatment strategiesBROWN, Elizabeth R; MAWHINNEY, Samantha; JONES, Richard H et al.Statistics in medicine. 2001, Vol 20, Num 16, pp 2489-2504, issn 0277-6715Article

Immune reconstitution inflammatory syndrome: incidence and implications for mortalityNOVAK, Richard M; RICHARDSON, James T; BUCHACZ, Kate et al.AIDS (London). 2012, Vol 26, Num 6, pp 721-730, issn 0269-9370, 10 p.Article

Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1―Infected PatientsDEJESUS, Edwin; YOUNG, Benjamin; MCCOLL, Damian et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 2, pp 163-174, issn 1525-4135, 12 p.Article

Kidney Disease in Patients with HIV Infection and AIDSWINSTON, Jonathan; DERAY, Gilbert; HAWKINS, Trevor et al.Clinical infectious diseases. 2008, Vol 47, Num 11, pp 1449-1457, issn 1058-4838, 9 p.Article

Clinical assessment of HIV-associated lipodystrophy in an ambulatory populationLICHTENSTEIN, Kenneth A; WARD, Douglas J; MOORMAN, Anne C et al.AIDS (London). 2001, Vol 15, Num 11, pp 1389-1398, issn 0269-9370Article

FURTHER VALIDATION OF THE SYSTEMATIC SCREENING FOR BEHAVIOR DISORDERS IN MIDDLE AND JUNIOR HIGH SCHOOLRICHARDSON, Michael J; CALDARELLA, Paul; YOUNG, Benjamin J et al.Psychology in the schools. 2009, Vol 46, Num 7, pp 605-615, issn 0033-3085, 11 p.Article

First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sicknessSMITH, Terry K; YOUNG, Benjamin L; DENTON, Helen et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 6, pp 1749-1752, issn 0960-894X, 4 p.Article